Satos Corn and Callus Remover

Description

The drug is identified by the SPL Code 34089-3 and is packaged in a carton. An image of the carton is available for reference, labeled as "satoliqcorncart.jpg".

Uses and Indications

This drug is indicated for the removal of corns and calluses. It provides relief from pain associated with corns through its effective removal properties.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be washed and dried thoroughly prior to application. One drop of the product should be applied at a time using the provided applicator to ensure sufficient coverage of each corn or callus. After application, the area should be allowed to dry completely.

This procedure may be repeated once or twice daily as needed, for a maximum duration of 14 days, or until the corn or callus is removed. To enhance the effectiveness of the treatment, it is recommended to soak the corn or callus in warm water for 5 minutes prior to application.

Contraindications

Use of this product is contraindicated in the following situations:

Application on irritated skin is prohibited due to the potential for exacerbation of the condition. The product should not be applied to any area that is infected or reddened, as this may lead to further irritation or complications. Additionally, individuals with diabetes should avoid use, as the product may interfere with glycemic control. Patients with poor blood circulation are also advised against using this product, as it may pose risks related to compromised blood flow.

Warnings and Precautions

For external use only. This product is flammable; it is imperative to keep it away from fire or flame. The bottle should be capped tightly and stored at room temperature, away from heat sources.

General precautions must be observed when using this product. It should not be applied to irritated skin or any area that is infected or reddened. Individuals with diabetes or poor blood circulation should refrain from using this product. Additionally, users should avoid inhaling vapors during application.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

If discomfort persists after use, it is advised to discontinue use and consult a healthcare professional.

Side Effects

Patients should be advised against using this product on irritated skin, infected or reddened areas, and in individuals with diabetes or poor blood circulation. Inhalation of vapors should be avoided during use to prevent respiratory discomfort.

In the event that discomfort persists, patients are instructed to discontinue use and consult a healthcare professional. It is crucial to keep this product out of reach of children. If swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are no reported drug interactions associated with this medication. Additionally, there are no known interactions between this medication and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Satos Corn and Callus Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Satos Corn and Callus Remover in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

The product has not been evaluated for safety in pregnancy, and caution is advised due to the lack of established safety data regarding the use of salicylic acid during this period. While specific contraindications are not stated, potential risks associated with the use of salicylic acid during pregnancy remain undefined. Therefore, healthcare providers should be consulted prior to use in pregnant patients or those planning to become pregnant. No specific dosage modifications for pregnant individuals are provided, underscoring the importance of professional guidance in managing treatment during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of the compound's potential effects in these areas.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be instructed not to apply the product to irritated skin or any areas that are infected or reddened. It is also important to inform patients that the product is contraindicated for individuals with diabetes or those who have poor blood circulation.

While using the product, patients should be cautioned to avoid inhaling vapors. If any discomfort persists during use, patients should be advised to stop using the product and consult a healthcare professional for further guidance.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the bottle at room temperature, ensuring it is kept away from heat sources. Additionally, the product must be kept away from fire or flame to maintain safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Satos Corn and Callus Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)